Louisiana is asking the Supreme Court to stop abortion pills from being delivered through the mail, escalating a legal battle that has already roiled the lower federal courts.
The push comes after a federal appeals court temporarily halted an FDA rule that opened the door to much wider access to mifepristone, the drug used in medication abortion. That court order has created an opening for states seeking to restrict how the pill reaches patients.
Louisiana's move reflects a broader conservative strategy to chip away at abortion access in the post-Roe landscape. With the Supreme Court's 2022 decision returning abortion regulation to the states, red states have pursued multiple avenues to limit the procedure, and medication abortion has become a particular flashpoint.
The FDA regulation in question loosened restrictions that previously required patients to obtain mifepristone in person at a clinic or doctor's office. The expanded access made it possible for people to receive the pill by mail, which has been especially significant in states where in-person abortion care is unavailable or heavily restricted.
The federal appeals court's temporary block threw that expanded access into limbo, giving anti-abortion states and groups a tactical opening to ask the Supreme Court to make the block permanent. Louisiana's petition is part of that effort to keep the pill off mailboxes and out of patients' hands outside traditional clinical settings.
The case highlights how abortion battles are now being fought not just in state legislatures but in federal courts, with access to medication abortion proving to be one of the most contentious front lines.
Author Sarah Mitchell: "This is Louisiana's real play: not just blocking abortion in the state, but ensuring the Supreme Court keeps the brake on nationwide pill access while the merits grind on."
Comments